Disclosure Policy
We believe that readers need to be aware
of any affiliation or financial relationship (consultancies,
honoraria, research grants, speaker's bureau, etc.)
between an author or members of the CME Advisory
Board and any organization or entity that has a
direct financial interest in the subject matter
of the materials about which this monograph is written.
We therefore obtain a completed disclosure form
to inform the program participant of any pertinent
relationships disclosed, provided here:
| Disclosures |
| CME
Advisory Committee |
| Dr. Abrams: |
Consultant, Coca Cola Corporation |
| Dr. Andrews: |
Consultant, Eli Lilly, Procter and Gamble;
Speakers Bureau, Wyeth and Ortho |
| Dr. Bates: |
Nothing to disclose |
| Dr. Campbell: |
Nothing to disclose |
| Dr. Cohen: |
Clinical Investigator and Research Consultant,
Merck, Aventis, Procter and Gamble, Pfizer,
Boehringer Ingelheim, Centocor, Amgen, Scios,
and Wyeth-Ayerst |
| Dr. Fitzpatrick: |
Research grant, Amgen |
| Dr. Greenwald: |
Clinical research, Abbott, Allelix, Amgen,
Aventis, Biogen, BMS, Boehringer Mannheim,
Genentech, Glaxo SmithKline, IDE, Lilly, Merck,
National Institutes of Health, Ortho-McNeill,
Pfizer, Procter and Gamble, Roche, Xoma |
| Dr. Haramati: |
Nothing to disclose |
| Dr. Hochberg: |
Research grant, Arthritis Foundation,
Glaxo SmithKline, National Institutes of
Health. Consultant, Abbott Laboratories,
Amgen, Arakis Limited Astra-Zeneca, Aventis
Pharmaceutical Co., Inc., Bristol-Myers
Squibb, Eli Lilly, Genzyme, Laboratories
NEGMA, Merck, Novartis, Procter and Gamble,
Purdue Pharma, Roche, Scios, Takeda Pharmaceuticals
North America. Stock Shareholder, Johnson
and Johnson |
| Dr. Johnston: |
Consultant, Eli Lilly, Merck, Alliance
for Better Bone Health, Procter and Gamble
and Aventis |
| Ms. Kessenich: |
Consultant, Procter and Gamble and Eli
Lilly |
| Dr. Legato: |
Nothing to disclose |
| Dr. Lyles: |
Research grants, Novartis, Procter and
Gamble.
Speakers Bureau, Novartis, Procter and
Gamble and Merck. Consultant, Novartis |
| Dr. Miller: |
Nothing to disclose |
| Dr. Petak: |
Speakers Bureau, Eli Lilly, Procter and
Gamble, Aventis |
| Dr. Rosen: |
Research grants, Aventis, Eli Lilly, Merck,
NPS, Novartis, Wyeth |
| Dr. Schiff: |
Speakers Bureau, Wyeth-Ayerst, Solvay,
Procter and Gamble, Merck, Aventis, Eli
Lilly, Berlex. Boards, Merck-Medco and North
American Menopause Society |
| Dr. Watts: |
Consultant, Aventis, Eli Lilly, Merck,
Procter and Gamble, Novartis, Wyeth. Research
grants, Amgen, Aventis, Eli Lilly, Merck,
Novartis, Procter and Gamble |
| Editorial Staff |
| Dr. Brown: |
Nothing to disclose |
| Dr. Evans: |
Nothing to disclose |
| Dr. Karet: |
Nothing to disclose |
| Ms. Fitzgerald: |
Nothing to disclose |
Disclosure of Off-Label Uses
The content of this CME program may contain
discussion of off-label uses of some of the agents
mentioned. Please consult the product prescribing
information for full disclosure of labeled uses.
|
